Related Experiment Video
Updated: Jan 17, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.6K
Cardiovascular risk among Giant cells arteritis patients
Alexis F Guedon1,2, Olivier Espitia3, Maxime Beydon4
1Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
European Journal of Preventive Cardiology
|January 15, 2026
Summary
Giant cell arteritis (GCA) significantly elevates the risk of major cardiovascular events, including aortic and peripheral artery disease. Managing inflammation and cardiovascular risk factors is crucial for patients with GCA.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Giant cell arteritis (GCA) is a chronic inflammatory condition affecting large arteries, predominantly in older adults.
- GCA is associated with a substantial burden of cardiovascular (CV) complications.
- Understanding the specific CV risks and their drivers in GCA is vital for effective patient management.
Purpose of the Study:
- To assess the association between GCA and the risk of various cardiovascular events.
- To evaluate the impact of traditional CV risk factors and GCA disease activity on these outcomes.
Main Methods:
- A cohort of 23,193 patients diagnosed with incident GCA (aged ≥50 years) was identified from the French National Health Data System (2012-2022).
- Patients were propensity score-matched to a general population cohort and a hospitalized cohort.
- Primary outcomes included aortic events, major adverse cardiovascular events (MACE), peripheral artery disease (PAD) events, and visceral artery events.
Main Results:
- GCA patients exhibited significantly increased risks for all assessed CV outcomes compared to the general population.
- Compared to the hospitalized cohort, GCA patients showed increased risks for all outcomes except MACE.
- GCA disease activity was independently associated with a higher risk of MACE.
Conclusions:
- GCA is a significant risk factor for diverse vascular complications.
- Effective cardiovascular risk management and control of inflammation are essential for GCA patients.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
447
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
447
01:30Coronary Artery Disease I: Introduction
882
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
01:26Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
01:27Psychoneuroimmunology: Cardiovascular Disease
402
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
402
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
540
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540